Additional details
Indication (or studied pathology) : Soins Intensifs
Brugmann identifier : EPICIII
EudraCT identifier :
B406201732918
Resources
Involved department : Intensive care
Principal investigator : De Bels
Sponsor :
Contact : Clinical Research Unit
This protocol was approved by the Erasme ethics committee.